Security Snapshot

Eloxx Pharmaceuticals, Inc. - Common Stock, $0.01 par value per share (ELOX) Institutional Ownership

CUSIP: 29014R301

13F Institutional Holders and Ownership History from Q2 2026 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

13

Shares (Excl. Options)

1.9MFull value: 1,897,747 · shares · 30 Sep 2026

Price

$15.31

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock, $0.01 par value per share
Symbol
ELOX on Nasdaq
All holders as of 30 Sep 2026
Q3 2026
Total 13F shares
1,897,747
Latest holder snapshot 5 signals
Total 13F value
$29,054,506
Portfolio coverage rank
0%
Share change
+208,916
Value change
+$3,198,502
Number of holders
13
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
4,076,626
SEC-reported price per share
$12.70
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • ELOX - Eloxx Pharmaceuticals, Inc. - Common Stock, $0.01 par value per share is tracked under CUSIP 29014R301.
  • 13 institutions reported positions in Q3 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 22 to 13 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $34.7MFull value: $34,695,672 · USD · 30 Jun 2026
    to
    $29.05MFull value: $29,054,506 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 13 institutions filings for Q3 2026.

Open SEC evidence

Security key

29014R301

13F reference period

Q3 2026

13F holders

13

13D/G owners

6

CIK / CUSIP context first

Open Q3 2026 holders ELOX full holder history Eloxx Pharmaceuticals, Inc. SEC filings Eloxx Pharmaceuticals, Inc. company facts Eloxx Pharmaceuticals, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
ELOX
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Domicilium Real Estate Fund III LP 20% +302% 854,973 +3542% Domicilium Capital Partners LLC 05 Jun 2026
Invus Global Management, LLC 10% 403,586 Raymond Debbane 09 Jun 2026
EcoR1 Capital, LLC 9.9% 403,586 EcoR1 Capital, LLC 09 Jun 2026
Samsara BioCapital, L.P. 9.9% $4,580,701 403,586 Srinivas Akkaraju 10 Jun 2026
Stonepine Capital Management, LLC 9.9% 403,228 Stonepine Capital Management, LLC 09 Jun 2026
Nantahala Capital Management, LLC 9.9% $4,540,000 400,000 Nantahala Capital Management, LLC 30 Jun 2026
As of 30 Sep 2026, 13 institutional investors reported holding
1.9MFull value: 1,897,747 · shares · 30 Sep 2026
shares of Eloxx Pharmaceuticals, Inc. - Common Stock, $0.01 par value per share (ELOX). This represents 47% of the company’s total
4.08MFull value: 4,076,626 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 13 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
47%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Siren, L.L.C. 9.8% 400,000 0% 0.15% $6,124,000
Aberdeen Group plc 9.8% 400,000 0% 0.01% $6,124,000
Nantahala Capital Management, LLC 9.8% 400,000 0% 0.34% $6,124,000
Stonepine Capital Management, LLC 9.4% 381,977 -3.8% 4.9% $5,848,068
MORGAN STANLEY 5% 202,630 +13024% 0% $3,102,265
VANGUARD CAPITAL MANAGEMENT LLC 1.9% 78,680 0% 0% $1,204,591
GEODE CAPITAL MANAGEMENT, LLC 0.49% 19,946 0% $305,372
VANGUARD FIDUCIARY TRUST CO 0.34% 13,669 +29% 0% $209,272
Vanguard Global Advisers, LLC 0.02% 718 0% 0% $10,993
Pioneer Family Office, LLC 0% 96 0% 0% $1,470
Altshuler Shaham Ltd 0% 25 0% 0% $383
Activest Wealth Management 0% 4 0% 0% $61
SBI Securities Co., Ltd. 0% 2 0% 0% $31

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
2
Headline period
Q3 2026
Rows shown
1-2 of 2
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 1,897,747 $29,054,506 +$3,198,502 $15.31 13
2026 Q2 2,499,714 $34,695,672 +$34,695,672 $13.88 22
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .